Item 7.01 Regulation FD Disclosure.

On July 13, 2022, Apollo Endosurgery, Inc. (the "Company") issued a press release announcing the marketing authorization of the Apollo ESGTM, Apollo ESG SxTM, Apollo REVISETM and Apollo REVISE SxTM Systems through the U.S. Food and Drug Administration's ("FDA") De Novo Classification process, which press release is attached as Exhibit 99.1 to this report.

The press release attached to this report as Exhibit 99.1 is furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or subject to the liabilities of that section. The information contained in the press release attached to this report as Exhibit 99.1 shall not be deemed incorporated by reference into any other filing with the Securities and Exchange Commission (the "SEC") made by the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.




Item 8.01  Other Events.

On July 13, 2022, the Company announced the marketing authorization of the Apollo ESGTM, Apollo ESG SxTM, Apollo REVISETM and Apollo REVISE SxTM Systems through the FDA's De Novo Classification process. In a randomized controlled trial, the ESG procedure demonstrated safety and effectiveness with durability out to two years. The Apollo ESG and Apollo ESG Sx Systems are intended to be used by trained gastroenterologists or surgeons to facilitate weight loss in adults with obesity with Body Mass Index (BMI) between 30-50 kg/m2 who have not been able to lose weight or maintain weight loss through more conservative measures. The Apollo REVISE and Apollo REVISE Sx Systems are intended to be used by trained gastroenterologists or surgeons that perform bariatric procedures to facilitate weight loss in adult patients with obesity with BMI between 30-50 kg/m2 by enabling transoral outlet reduction (TORe) as a revision to a previous bariatric procedure.

Item 9.01 Financial Statements and Exhibits.



(d)  Exhibits
   Exhibit No.          Description of Document
                          Press release, issued by Apollo Endosurgery, Inc., dated July     13    ,
99.1                    2022.
104                     Cover Page Interactive Data File (embedded within the Inline XBRL document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses